Skip to content

Ardelyx ARDX Gross Profit

Discontinued — last reported Q1 '26

Gross Profit at other companies

Amgen logo
AmgenAMGN
$5.87B+13.4%
AbbVie logo
AbbVieABBV
$10.78B+15.4%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$71.2M+32.1%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$19.43M+154%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+25.5%
Enterprise value$1.71B+27.1%
P/S3.6×+0.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Calculated from Ardelyx’s reported figures.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's gross profit?
Ardelyx (ARDX) reported gross profit of $89.66M in Q1 2026.
How has Ardelyx's gross profit changed year-over-year?
Ardelyx's gross profit increased by 45.1% year-over-year, from $61.81M to $89.66M.
What is the long-term trend for Ardelyx's gross profit?
Over 4 years (2021 to 2025), Ardelyx's gross profit has grown at a 152.2% compound annual growth rate (CAGR), from $9.1M to $367.78M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.